Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Camargo Appoints Corporate Development VP | Contract Pharma
Breaking News

Camargo Appoints Corporate Development VP

Bolin will work to advance strategic financial and technical partnerships

Camargo Pharmaceutical Services has appointed Mark Bolin as vice president of corporate development. Mr. Bolin will use his 25 years of pharmaceutical and health care industry experience to advance the company through strategic financial and technical partnerships.
 
“Camargo’s recent expansion with the opening of our Durham, N.C., office and the potential to open additional offices will extend our company’s reach to clients around the globe, while making our extensive regulatory expertise available to meet the increasing demand in formulation, preclinical and clinical services,” said Ken Phelps, president and chief executive officer. “Mark will serve as the business arm and his substantial experience setting companies up for growth via financial and operational management will be an asset to Camargo.”
 
Prior to joining the company, Mr. Bolin served as a founding member and chief financial officer of Ricetta Rx Holdings LLC, where he helped secure a long-term care pharmacy business through acquisition and organic growth. Mr. Bolin was responsible for identifying and targeting acquisition candidates, negotiating acquisition terms and asset purchase agreements, and managing the financial operations of the company. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters